The aim of this study is to use proteomic analysis to identify biochemical changes in individuals at higher risk of developing ALS or FTD via C9orf72 HRE heterozygosity, using both a candidate protein and unbiased approach. This evidence concerns the gene C9orf72 and frontotemporal dementia.